Antiarrhythmic drugs for atrial fibrillation in the outpatient setting

被引:0
作者
Tseng, Andrew S. [1 ]
Desimone, Christopher V. [1 ]
Kowlgi, Gurukripa N. [1 ]
机构
[1] Mayo Clin, Dept Cardiovas Med, Rochester, MN USA
关键词
Atrial fibrillation; Cardiac arrhythmias; Outpatients; DIRECT ORAL ANTICOAGULANTS; HEART-FAILURE; DIGOXIN; DRONEDARONE; CAFFEINE; RISK; METAANALYSIS; ASSOCIATION; ARRHYTHMIAS; DOFETILIDE;
D O I
10.23736/S0026-4806.23.08524-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With burgeoning evidence for early rhythm control in patients with atrial fibrillation (AF), the management of AF in the outpatient setting has become more challenging. The primary care clinician often serves as the frontline in the pharmacologic management of AF. Because of drug interactions and the risk of proarrhythmia, many clinicians remain hesitant about the initiation and chronic management of antiarrhythmic drug prescriptions. However, with the likely increased use of antiarrhythmics for early rhythm control, understanding and familiarity with these medications have likewise become more important, especially since patients with AF probably have other non-cardiac medical conditions that can impact their antiarrhythmic therapy. In this comprehensive review, we provide informative, high-yield cases and edifying references that will help primary care providers become comfortable handling various clinical scenarios.
引用
收藏
页码:839 / 849
页数:11
相关论文
共 50 条
  • [1] Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician
    Tseng, Andrew S.
    Kowlgi, Gurukripa N.
    V. DeSimone, Christopher
    MAYO CLINIC PROCEEDINGS, 2021, 96 (08) : 2230 - 2242
  • [2] Antiarrhythmic drugs for atrial fibrillation
    Marinelli, Alessandro
    Capucci, Alessandro
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1201 - 1215
  • [3] New Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation
    Schmitt, Joern
    Ehrlich, Joachim R.
    Hohnloser, Stefan H.
    HERZ, 2008, 33 (08) : 562 - 567
  • [4] The new antiarrhythmic drugs for the treatment of atrial fibrillation
    Botto, Giovanni Luca
    Russo, Giovanni
    Mariconti, Barbara
    Pentimalli, Francesco
    Campana, Carlo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2012, 13 (10) : 10S - 15S
  • [5] Can Polymorphisms Predict Response to Antiarrhythmic Drugs in Atrial Fibrillation?
    Daubert, James P.
    Pitt, Geoffrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (06) : 546 - 547
  • [6] Emerging Antiarrhythmic Drugs for Atrial Fibrillation
    Saljic, Arnela
    Heijman, Jordi
    Dobrev, Dobromir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [7] The role of antiarrhythmic drugs in atrial fibrillation
    Bontempi, Luca
    Vassanelli, Francesca
    Lipari, Alessandro
    Pagnoni, Carlo
    Locantore, Elisa
    ElMaghawry, Mohamed
    Salghetti, Francesca
    Cerini, Manuel
    Curnis, Antonio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2013, 14 (03) : 76S - 81S
  • [8] Current antiarrhythmic drug therapy in atrial fibrillation
    Goette, A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 : S33 - S37
  • [9] New Class III Antiarrhythmic Drugs for Treatment of Atrial Fibrillation
    Maykov, E. B.
    KARDIOLOGIYA, 2012, 52 (11) : 56 - 65
  • [10] Epidemiology and management of coexisting heart failure and atrial fibrillation in an outpatient setting
    Rewiuk, Krzysztof
    Wizner, Barbara
    Fedyk-Lukasik, Malgorzata
    Zdrojewski, Tomasz
    Opolski, Grzegorz
    Dubiel, Jacek
    Gasowski, Jerzy
    Grodzicki, Tomasz
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (11): : 392 - 398